McSPI: The Multicenter Study of Perioperative Ischemia
Publication
Title Impact of pexelizumab, an anti-C5 complement antibody, on total mortality and adverse cardiovascular outcomes in cardiac surgical patients undergoing cardiopulmonary bypass.  
Date Published 2004 
Journal Ann Thorac Surg 2004;77:942-949. 
Authors Shernan SK, Fitch JCK, Nussmeier NA, Chen JC, Rollins SA, Mojcik CF, Malloy KJ, Todaro TG, Filloon T, Boyce SW, Gangahar DM, Goldberg M, Saidman LJ, Mangano DT and the Pexelizumab Study Investigators 
Abstract